BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35052318)

  • 1. Artificial Intelligence Analysis of Gene Expression Predicted the Overall Survival of Mantle Cell Lymphoma and a Large Pan-Cancer Series.
    Carreras J; Nakamura N; Hamoudi R
    Healthcare (Basel); 2022 Jan; 10(1):. PubMed ID: 35052318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial Neural Networks Predicted the Overall Survival and Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Pancancer Immune-Oncology Panel.
    Carreras J; Hiraiwa S; Kikuti YY; Miyaoka M; Tomita S; Ikoma H; Ito A; Kondo Y; Roncador G; Garcia JF; Ando K; Hamoudi R; Nakamura N
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34945004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial Intelligence Predicted Overall Survival and Classified Mature B-Cell Neoplasms Based on Immuno-Oncology and Immune Checkpoint Panels.
    Carreras J; Roncador G; Hamoudi R
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Intelligence Analysis of Celiac Disease Using an Autoimmune Discovery Transcriptomic Panel Highlighted Pathogenic Genes including BTLA.
    Carreras J
    Healthcare (Basel); 2022 Aug; 10(8):. PubMed ID: 36011206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial Intelligence Analysis of Ulcerative Colitis Using an Autoimmune Discovery Transcriptomic Panel.
    Carreras J
    Healthcare (Basel); 2022 Aug; 10(8):. PubMed ID: 36011133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial Intelligence Analysis of Gene Expression Data Predicted the Prognosis of Patients with Diffuse Large B-Cell Lymphoma.
    Carreras J; Hamoudi R; Nakamura N
    Tokai J Exp Clin Med; 2020 Apr; 45(1):37-48. PubMed ID: 32219808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network.
    Rauert-Wunderlich H; Mottok A; Scott DW; Rimsza LM; Ott G; Klapper W; Unterhalt M; Kluin-Nelemans HC; Hermine O; Hartmann S; Thorns C; Rymkiewicz G; Holte H; Dreyling M; Hoster E; Rosenwald A
    Br J Haematol; 2019 Feb; 184(4):616-624. PubMed ID: 30095158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy.
    Holte H; Beiske K; Boyle M; Trøen G; Blaker YN; Myklebust J; Kvaløy S; Rosenwald A; Lingjaerde OC; Rimsza LM; Smeland EB; Scott DW; Kolstad A
    Br J Haematol; 2018 Oct; 183(2):225-234. PubMed ID: 30080252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical laboratory validation of the MCL35 assay for molecular risk stratification of mantle cell lymphoma.
    Ramsower CA; Maguire A; Robetorye RS; Feldman AL; Syrbu SI; Rosenthal AC; Rimsza LM
    J Hematop; 2020 Dec; 13(4):231-238. PubMed ID: 33193905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High PTX3 expression is associated with a poor prognosis in diffuse large B-cell lymphoma.
    Carreras J; Kikuti YY; Hiraiwa S; Miyaoka M; Tomita S; Ikoma H; Ito A; Kondo Y; Itoh J; Roncador G; Martinez A; Colomo L; Hamoudi R; Ando K; Nakamura N
    Cancer Sci; 2022 Jan; 113(1):334-348. PubMed ID: 34706126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic value of secreted protein acidic and rich in cysteine in the diffuse large B-cell lymphoma.
    Pan PJ; Liu JX
    World J Clin Cases; 2021 Aug; 9(22):6287-6299. PubMed ID: 34434995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial.
    Bomben R; Ferrero S; D'Agaro T; Dal Bo M; Re A; Evangelista A; Carella AM; Zamò A; Vitolo U; Omedè P; Rusconi C; Arcaini L; Rigacci L; Luminari S; Piccin A; Liu D; Wiestner A; Gaidano G; Cortelazzo S; Ladetto M; Gattei V
    Haematologica; 2018 May; 103(5):849-856. PubMed ID: 29472356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome.
    Zoldan MC; Inghirami G; Masuda Y; Vandekerckhove F; Raphael B; Amorosi E; Hymes K; Frizzera G
    Br J Haematol; 1996 May; 93(2):475-86. PubMed ID: 8639452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma.
    Li WX; Dai SX; An SQ; Sun T; Liu J; Wang J; Liu LG; Xun Y; Yang H; Fan LX; Zhang XL; Liao WQ; You H; Tamagnone L; Liu F; Huang JF; Liu D
    Aging (Albany NY); 2021 Apr; 13(8):11833-11859. PubMed ID: 33885377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon gamma inducible protein 16 (IFI16) expression is reduced in mantle cell lymphoma.
    Piccaluga PP; Navari M; Visani A; Rigotti F; Agostinelli C; Righi S; Diani E; Ligozzi M; Carelli M; Ponti C; Bon I; Zipeto D; Landolfo S; Gibellini D
    Heliyon; 2019 Nov; 5(11):e02643. PubMed ID: 31840115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctival Lymphoma--An International Multicenter Retrospective Study.
    Kirkegaard MM; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Toft PB; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
    JAMA Ophthalmol; 2016 Apr; 134(4):406-14. PubMed ID: 26891973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large cell variants of CD5+, CD23- B-cell lymphoma/leukemia.
    Dunphy CH; Perkins SL
    Arch Pathol Lab Med; 2001 Apr; 125(4):513-8. PubMed ID: 11260626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
    Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
    J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomic features of glucose metabolism enable prediction of outcome in mantle cell lymphoma.
    Mayerhoefer ME; Riedl CC; Kumar A; Gibbs P; Weber M; Tal I; Schilksy J; Schöder H
    Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2760-2769. PubMed ID: 31286200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.